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Objective:   The optimal diet for weight loss in type 2 diabetes remains controversial. This study examined a low-carbohydrate, high-fat diet with detailed physiological assessments of insulin sensitivity, glycaemic control, and risk factors for cardiovascular disease.
Methods: 14 obese patients (BMI 40.6 4.9 kg/m2) with type 2 diabetes were recruited for an “Atkins” type low-carbohydrate diet.  Measurements were made at 0, 12 and 24 weeks of weight, insulin sensitivity, HbA1c, lipids and blood pressure.
Results: 12 completers lost a mean of 9.7  1.8kg over 24 weeks attributable to a major reduction in carbohydrate and resultant reduction in total energy intake. Glycaemic control significantly improved (HbA1c -1.10.25%) with reductions in hypoglycaemic medication. Fasting glucose, HOMA and AUC glucose (IVGTT) were significantly reduced by week 12 (p<0.05).  There were non-significant improvements in insulin sensitivity (SI) at weeks 12 (p =0.19) and 24 (p=0.31). Systolic blood pressure reduced (mean -10.0mmHg between week 0 and 24 (p=0.13). Mean HDL, LDL and total cholesterol all increased.  The ratio of total:HDL cholesterol and triglycerides reduced.
Conclusion: A low-carbohydrate diet was well tolerated and achieved weight loss over 24 weeks in subjects with diabetes.  Glycaemic control improved with a reduction in requirements for hypoglycaemic agents.
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Introduction: Obesity and type 2 diabetes have reached epidemic proportions worldwide with major implications for individual health outcomes and health care resources [1].  There is an urgent need to find effective dietary strategies to manage weight, glucose homeostasis and risk factors for cardiovascular disease. Weight loss in patients with type 2 diabetes improves glycaemic control, largely by improving insulin sensitivity [2]. However, the most appropriate dietary macronutrient composition of a weight reduction diet remains controversial, particularly in individuals with Type 2 diabetes. Current recommendations by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), promote reduced energy intake with reduced fat, and a relatively high intake of carbohydrate (45-60% of total daily energy)  ADDIN EN.CITE [3-4]. 

Diets high in fat are associated with development of obesity, primarily due to passive over-consumption [5], and there is evidence to support a low-fat, high-carbohydrate diet in promoting weight loss [3]. However, there is some evidence that diets high in carbohydrate result in an exaggerated insulin response and elevated triglycerides, potentially increasing risk for cardiovascular disease [6-7]. This concern fuels the notion that a low-carbohydrate, high-fat diet may be more beneficial in promoting weight loss with improvements in insulin resistance and health outcomes. Low carbohydrate diets, particularly the “Atkins diet”[8], have received considerable attention in popular press and are endorsed by high profile celebrities.  However, there is surprisingly little evidence to support the claims for low carbohydrate diets [9-10].  

Studies in people without diabetes have shown greater initial weight loss at 6 and even 12 months, but no difference by 2 years when comparing low carbohydrate diets with low fat diets or high protein diets  ADDIN EN.CITE [11-17].  Some authors have concluded that the macronutrient composition is less important than adherence when it comes to achieving weight loss per se [18]. These studies have prompted the American Diabetes Association to alter their dietary guidelines to state that for short-term weight loss either a low-fat or low-carbohydrate calorie-restricted diet may be effective [4, 19].  However, what remains unclear is whether in people with established diabetes in the setting of weight loss, does the macronutrient composition of the diet affect the metabolic profile and risk factors for cardiovascular disease. Concerns exist about the use of a low-carbohydrate high-fat diet in people with Type 2 diabetes and the potential associations with a worsening of the lipid profile, cardiovascular risk factors and deterioration in renal function [10, 20]. Additionally recent data suggest that a low-carbohydrate diet including predominantly animal protein may increase cardiovascular mortality, whereas a protein source may reduce all cause mortality [21]. 

Several small and very short studies ranging from seven days to five weeks have variably demonstrated reduced glucose and insulin concentrations and improved glycaemic control  ADDIN EN.CITE [22-25]. Gannon et al demonstrated in a weight neutral five week crossover study of individuals with poorly controlled type 2 diabetes on no medication that substituting protein for carbohydrate reduced HbA1c by reducing postprandial glucose [22].  In the longest trial currently reported, Davis et al demonstrated similar modest weight loss but no significant improvement in glycaemic control in those with type 2 diabetes on a low-fat or low-carbohydrate diet after one year [26].

From the studies conducted to date it is unclear whether changes in glucose metabolism with low-carbohydrate diets are simply due to reduced absorption of glucose or whether there are also changes in insulin sensitivity.  Therefore this pilot study was conducted to examine the effects of a low carbohydrate, high fat diet, on body weight and composition, with detailed physiological assessments of insulin sensitivity, glycaemic control, and risk factors for cardiovascular disease specifically in patients with type 2 diabetes. 

Methods: Fourteen overweight individuals with type 2 diabetes were recruited through the hospital diabetes clinic and newspaper advertising, and prescribed a low carbohydrate, high fat/protein diet (LCHF) for six months. Subjects were included if they had known established type 2 diabetes and were either diet controlled or required oral hypoglycaemic agents or insulin, were aged between 30 and 65 yrs and had a BMI between 30 and 50 kg/m2. Exclusion criteria were pregnancy or lactation, severe kidney or liver disease, malignancy, severe cardiovascular disease (New York Heart Association classification III and IV), drug or alcohol dependency, current or recent weight loss >3kg in previous three months, chronic inflammatory disease, steroid or other anti-inflammatory medications, lipid lowering therapy. Ethical approval for this investigation was granted by the New Zealand Ministry of Health central regional ethics committee. 

Dietary Intervention
Subjects were prescribed a low-carbohydrate diet based on the Dr Atkin’s Diet Revolution book with fat intake >40% of total energy intake and reduced carbohydrate intake [8]. This was divided into three phases; Induction phase (weeks 1-2) – restricting carbohydrate to <20g/day. Weight loss phase (weeks 3-12) – 5g additional carbohydrate intake per week until overall composition is 20-25% carbohydrate, 30% protein and 45 – 50% fat. Maintenance phase (weeks 12-24) – continued 5g additional carbohydrate per week until weight is stable without weight gain. Subjects attended 12 group sessions with a dietitian over the 24 weeks. Lists of food choices and menu ideas were provided and subjects were advised to take a general multivitamin supplement. Subjects were free-living making their own food choices based on these guidelines. All participants were encouraged to maintain their current levels of physical activity and not to increase this during the six months of the study. 

Compliance 
Compliance with the prescribed diet was assessed by three day non-weighed food diaries including two week days and one weekend day at baseline, 12 and 24 weeks using the 2006 New Zealand Food Composition Database, and urinary ketones.  

Outcome Measurements
Subjects attended for investigations between 0800 and 0900 at baseline (week 0) 12 and 24 weeks and had the following measurements: Weight, waist circumference (smallest circumference between lower ribs and iliac crest) and body fat measured using bioimpedence techniques (Internal equation of theTanita-305 body fat analyser Tanita Corp., Tokyo, Japan). Resting seated blood pressure was measured three times and the average of the second and third measures taken.  
HbA1c, lipid profile and serum creatinine were measured using standard commercial assays (Roche diagnostics) by an accredited laboratory (Diabetes and Lipid Laboratory, University of Otago, Dunedin).  A 24-hour urine sample was collected for assessment of proteinuria. Requirement for oral hypoglcaemic agents and insulin are described. Subjects underwent a frequently sampled insulin-modified  intravenous glucose tolerance test (IVGTT) [27]. The protocol used was that modified by Ward et al employing an insulin infusion, rather than bolus administration, to maximise the ability to determine insulin sensitivity (SI) in subjects with diabetes [28]. However insulin sensitivity was poorly defined using the typical minimal model in several subjects.  Therefore, alternative methods of estimating insulin sensitivity were also used. First the homeostasis model assessment (HOMA) was calculated using the standard formula [29].  Second, the area under the curve for glucose from the IVGTT was evaluated using the trapezium rule. Third, insulin sensitivity was evaluated using a modified dynamic insulin sensitivity and secretion test (DISST) model [30-31]. The model has an added glomerular glucose filtration term [32] as several subjects had significantly elevated fasting hyperglycaemia. Model variables, including SI are identified with the iterative integral method  ADDIN EN.CITE [33-34].  For more detail see appendix i.

Statistics and Data Analysis
Based on previous studies by the investigators, weight loss of 10% body weight is achievable with the conventional dietary prescription over 24 weeks [35-36]. In obese insulin resistant non-diabetic subjects this was associated with a mean 50% improvement in insulin sensitivity using an IVGTT [35].  It is unknown whether similar improvements are likely in those with diabetes on a low carbohydrate, high fat/protein diet. This pilot study will enable more accurate power calculations to be made to carefully design a larger prospective randomised dietary intervention study to compare low-fat with low-carbohydrate dietary prescriptions. Data were analysed comparing baseline with 12 and 24 weeks using the non-parametric Wicoxon Signed Rank Test with a p<0.05 accepted as significant. The prospective dietary intervention study cohort size was determined using a bootstrap with replacement approach that incorporated reported coefficients of variation of SI [37].

Results:  14 obese patients (BMI 40.6  4.9 kg/m2), eight men and six women with type 2 diabetes (duration 5.0  3.7 yrs) were recruited.  Of these patients, 3 were using insulin, 7 were using oral hypoglycaemics and 4 had diet controlled diabetes.  Twelve of the 14 subjects recruited completed the 24 weeks. One subject withdrew for personal reasons at week 3 and the other was removed from the study at week 4 due to an exacerbation of a renal stone.  The remaining 12 subjects are included in this analysis and individual characteristics are shown in Table 1 and group mean data in Table 2. Subjects lost a mean of 8.5  1.2kg (7.1  0.9%) of body weight over 12 weeks and 9.7  1.8kg (8.2  1.5%) over 24 weeks.  This was achieved by a reduction in total energy intake attributable to a major reduction in carbohydrate intake and relatively small increases in absolute protein and fat intake (Figure 1).  This is despite the fact that no instruction to limit overall intake was given.

This weight loss was associated with significant improvements in glycaemic control (HbA1c) with improvements in insulin sensitivity as measured from the IVGTT (Table 3).  Fasting glucose decreased from a mean of 9.7mmol/L to 7.6 at week 12 (p =0.049) and 8.0 at week 24 (p =0.27). Fasting insulin decreased from a mean of 126.8 pmol/L at baseline to 81.7 at week 12 (p =0.09) and 102.8 at week 24 (p =0.26).  HOMA improved from a mean of 8.2 at baseline to 5.1 at week 12 (p =0.03) and 4.8 at week 24 (p =0.09). The AUC glucose was significantly reduced by week 12 (p=0.03).  There were non-significant improvements in insulin sensitivity (SI) at weeks 12 (p =0.19) and 24 (p=0.31). All of the 3 subjects on insulin had reductions in dose, as did some of those on oral hypoglycaemics.  Systolic blood pressure was reduced by a clinically significant degree (mean -5.3mmHg between week 0 and 12 (p=0.34) and -10.0mmHg between week 0 and 24 (p=0.13), although this did not reach statistical significance in this small sample.  Diastolic blood pressure did not change. Some subjects were able to reduce doses of anti-hypertensive medication. No change was observed in renal function or urinary protein excretion.

Changes in lipid profile were mixed (Table 2).  Mean total cholesterol concentrations increased, which was a combination of increased HDL cholesterol and LDL cholesterol.  The ratio of total:HDL cholesterol reduced as did triglyceride concentrations, though neither reached statistical significance using non-parametric tests in this small sample.  

Discussion: A low carbohydrate diet was well tolerated and achieved weight loss associated with a reduction in total energy intake over 24 weeks in subjects with type 2 diabetes.  Glycaemic control improved with a reduction in requirements for hypoglycaemic agents, and there were no clear overall adverse effects on cardiovascular risk factors or renal function.  This provides support for this dietary approach, at least in the short-term, for promoting weight loss in patients with type 2 diabetes.  

Although the “Atkins” dietary prescription does not include specific instruction to reduce total energy intake, this pilot study has confirmed the findings of previous studies that by removing carbohydrate from the diet, compensatory increases in fat and protein intake do not bring total energy intake back up to baseline.  This supports the conclusions of Boden et al that weight loss is not due to the generation of ketosis, but simply due to the reduction in energy intake  ADDIN EN.CITE [25].

There was a clear improvement in glucose metabolism, with reductions in hypoglycaemic medications, particularly insulin doses, and clinically and statistically significant reductions in HbA1c. This confirms the changes observed by Boden et al  ADDIN EN.CITE [25] over just a 7 day intervention and those of Nuttel and Gannon  ADDIN EN.CITE [22-24]. However, the reduction in HbA1c of 1.3% is particularly impressive in comparison, especially with the non-significant change seen by Davis et al [26]. There was a statistically significant improvement in fasting glucose, HOMA and AUC glucose during the IVGTT and non-significant improvements in fasting insulin.  These findings are similar to that of Nuttel et al [24] where a diet with carbohydrate reduced to 30% of energy intake, but specifically tailored to be weight neutral over 5 weeks, showed reduction in fasting glucose and integrated glucose over 24 hours with standard meals, but no changes in insulin.  The individuals in that study were poorly controlled with higher baseline fasting glucose and HbA1c and were not taking glucose lowering medication.  The explanation for the metabolic improvements was concluded to be related to the reduced absorbed carbohydrate, and possibly to reduced stored glycogen. No specific assessment of insulin sensitivity was made. It is important to note that whilst the weight loss was maintained at 24 weeks, the metabolic improvements in fasting glucose, AUC glucose and fasting insulin were more variable, and a larger study over a longer period of weight maintenance on this diet would be required to determine whether initial benefits can be sustained.

In the present study, not only were there changes in macronutrient composition of the diet, but subjects also lost weight.  Therefore, it is likely that improvements in glucose metabolism are a composite of the changes proposed by Nuttell et al but also changes in insulin sensitivity [24].  The lack of statistically significant improvements in fasting insulin and whole body insulin sensitivity (SI) in this study may be due to several factors. In this very small sample the group data is skewed by 2 individuals. One (Number 8, Table 1) was considerably more insulin sensitive than the rest at baseline, had lower baseline insulin levels, was controlled with diet and was less overweight. This subject’s diabetes is likely to be driven more by reduced beta cell function than insulin resistance.  Another individual (Number 10, Table 1) was unable to successfully achieve or maintain a low carbohydrate diet.  Consequently, his total energy intake, fat and protein intakes all increased. This was associated with weight gain and worsening of glycaemic control, insulin sensitivity and lipid profile.  However, based on the changes seen in this small sample, a sample size of 35-50 subjects would have given 80-90% power to detect a significant improvement in insulin sensitivity. 

The mean group data also hides somewhat greater individual variability in lipid profile changes. Although total cholesterol and LDL cholesterol increased, so did HDL cholesterol with no change in the ratio. Whilst there may be important changes in LDL particle size, not measured in this study, there is no evidence to suggest a major harmful effect on overall lipid profile. This supports the findings of Davis et al  who demonstrated a greater rise in HDL cholesterol with a low-carbohydrate diet compared with a low-fat diet, but no difference in other lipid parameters [26].  The reduction in triglycerides was non-significant unlike most reduced carbohydrate diets  ADDIN EN.CITE [22-24], but not seen by Davis [26], and probably reflects the small study cohort and the effect of non-adherence.   Some individuals had a deterioration in their overall lipid profile raising caution that low-carbohydrate high-fat diet may worsen lipid profiles. This effect can be particularly exacerbated if individuals are unsuccessful in losing weight, and as in an individual in this study, may be linked with further weight gain and risk of adverse health outcomes.
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